Randomized Trial on the Efficacy and Safety of Standard Versus Higher Bicarbonate Supplementation in CKD of Unknown Etiology
Kidney Int Rep
.
2024 Feb 12;9(5):1504-1507.
doi: 10.1016/j.ekir.2024.02.008.
eCollection 2024 May.
Authors
Swathy Raju
1
,
Karthikeyan Manoharan
1
,
Natarajan Ramachandran
1
,
Jayaprakash Sahoo
2
,
Balasubramanian Vairappan
3
,
Velkumary Subramaniyam
4
,
Sreejith Parameswaran
1
,
P S Priyamvada
1
Affiliations
1
Department of Nephrology, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India.
2
Department of Endocrinology, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India.
3
Department of Biochemistry, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India.
4
Department of Physiology, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India.
PMID:
38707819
PMCID:
PMC11068943
DOI:
10.1016/j.ekir.2024.02.008
No abstract available
Keywords:
alkali therapy; metabolic acidosis; sodium bicarbonate; tubulointerstitial diseases.